Cas:1185292-79-8 1-methyl-3-propyl-1h-pyrazole-5-carboxamide manufacturer & supplier

Chemical Name:1-methyl-3-propyl-1h-pyrazole-5-carboxamide

CAS.NO:1185292-79-8

Synonyms:1H-Pyrazole-5-carboxamide,1-methyl-3-propyl

Molecular Formula:C₈H₁₃N₃O

Molecular Weight:167.20800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:60.91000

Exact Mass:167.10600

LogP:1.17180

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-Pyrazole-5-carboxamide,1-methyl-3-propyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrazole-5-carboxamide,1-methyl-3-propyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazole-5-carboxamide,1-methyl-3-propyl Use and application,1H-Pyrazole-5-carboxamide,1-methyl-3-propyl technical grade,usp/ep/jp grade.

Related News: He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 1-methyl-3-propyl-1h-pyrazole-5-carboxamide manufacturer Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. 1-methyl-3-propyl-1h-pyrazole-5-carboxamide supplier The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday. 1-methyl-3-propyl-1h-pyrazole-5-carboxamide vendor It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305. 1-methyl-3-propyl-1h-pyrazole-5-carboxamide factory He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients.